Global Depression Drugs Market 2014-2018

Global Depression Drugs Market 2014-2018

Category : Pharmaceuticals
Published On : January  2014
Pages : 52



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

TechNavio's analysts forecast the Global Depression Drugs market to grow at a CAGR of 2.49 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in the number of patients suffering from depression. The Global Depression Drugs market has also been witnessing the growing awareness of depression drugs. However, the generic erosion of key blockbuster drugs could pose a challenge to the growth of this market. 
TechNavio's report, the Global Depression Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Depression Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space are GlaxoSmithKline plc, Eli Lilly & Co., Pfizer Inc., and Forest Laboratories Inc.
Other vendors mentioned in the report are Astra Zeneca plc, Bristol Myers Squibb Co., Mallinckrodt Pharmaceuticals Inc., Sanofi Aventis S.A., and Takeda Pharmaceutical Company Ltd.
Key questions answered in this report: 
What will the market size be in 2018 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

 

 

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report


03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape


06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Market Segmentation by Product Types

08. Market Segmentation by Category

09. Geographical Segmentation

10. Buying Criteria

11. Rate of Incidence and Prevalence

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Vendor Landscape


17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Market Share Analysis

17.3 Other Prominent Vendors

18. Key Vendor Analysis

18.1 GlaxoSmithKline plc

18.1.1 Business Overview

18.1.2 Business Segmentation

18.1.3 Key Information

18.1.4 SWOT Analysis

18.2 Eli Lilly & Co.

18.2.1 Business Overview

18.2.2 Key Information

18.2.3 SWOT Analysis

18.3 Pfizer Inc.

18.3.1 Business Overview

18.3.2 Business Segmentation

18.3.3 Key Information

18.3.4 SWOT Analysis

18.4 Forest Laboratories Inc.

18.4.1 Business Overview

18.4.2 Key Information

18.4.3 SWOT Analysis

19. Other Reports in this Series



List of Exhibits

Exhibit 1: Market Research Methodology

Exhibit 2: Global Depression Drugs Market 2013-2018 (US$ billion)

Exhibit 3: Global Depression Drugs Market Segmentation by Product Types

Exhibit 4: Global Depression Drugs Market Segmentation by Category

Exhibit 5: Global Depression Drugs Market by Geographical Segmentation 2013

Exhibit 6: Global Depression Drugs Market by Vendor Segmentation 2013

Exhibit 7: Business Segmentation of GlaxoSmithKline plc

Exhibit 8: Business Segmentation of Pfizer Inc.



 


Enquiry Before Buy
image
Can´t read the image ? refresh here.